- By insider

CFO & COO, Lab Operations of Medpace Holdings Inc (30-Year Financial, Insider Trades) Jesse J Geiger (insider trades) sold 3,000 shares of MEDP on 04/14/2021 at an average price of $180 a share. The total sale was $540,000.

• Warning! GuruFocus has detected 5 Warning Sign with MEDP. Click here to check it out.

• MEDP 15-Year Financial Data

• The intrinsic value of MEDP

• Peter Lynch Chart of MEDP

Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings Inc has a market cap of $6.48 billion; its shares were traded at around $179.900000 with a P/E ratio of 46.85 and P/S ratio of 7.33. Medpace Holdings Inc had an annual average EBITDA growth of 16.70% over the past 5 years.

CEO Recent Trades:

• President & CEO, 10% Owner August J. Troendle sold 52,518 shares of MEDP stock on 04/16/2021 at the average price of $184.09. The price of the stock has decreased by 2.28% since.

CFO Recent Trades:

• CFO & COO, Lab Operations Jesse J Geiger sold 3,000 shares of MEDP stock on 04/14/2021 at the average price of $180. The price of the stock has decreased by 0.06% since.

Directors and Officers Recent Trades:

• 10% Owner Investors, Llc Medpace sold 52,518 shares of MEDP stock on 04/16/2021 at the average price of $184.09. The price of the stock has decreased by 2.28% since.

• General Counsel & Corp. Secy. Stephen P Ewald sold 5,000 shares of MEDP stock on 04/15/2021 at the average price of $184.1. The price of the stock has decreased by 2.28% since.

For the complete insider trading history of MEDP, click here

.This article first appeared on GuruFocus.